Advances in Antibody–Drug Conjugates for Treatment of Non-Small-Cell Lung Cancer

Get up to date on integrating emerging antibody&ndash drug conjugates into the care of your patients with non-small-cell lung cancer with an interactive on-demand Webcast and downloadable slides with ExpressPoints slides from the virtual symposium.

Share

Program Content

Activities

FAQ: ADCs in NSCLC
Frequently Asked Questions on Emerging Antibody–Drug Conjugates in the Treatment of Advanced Non-Small-Cell Lung Cancer
Podcast Episodes
Congratulations: You achieved a completion on 04/09/2022

Released: March 17, 2021

Expires: March 16, 2022

Activities

<i>EP</i>: ADCs in NSCLC
ExpressPoints: Advances in Antibody–Drug Conjugates for Treatment of Non-Small-Cell Lung Cancer
Slideset Download
Congratulations: You achieved a completion on 04/09/2022

Released: March 04, 2021

Expires: March 03, 2022

Introducing ADCs in NSCLC
Introduction to Antibody–Drug Conjugates for Treatment of Non-Small-Cell Lung Cancer
Slideset Download
Congratulations: You achieved a completion on 04/09/2022

Released: February 09, 2021

Expires: February 08, 2022

ADCs in NSCLC trials
Activity of Antibody Drug Conjugates in NSCLC Clinical Trials
Slideset Download
Congratulations: You achieved a completion on 04/09/2022

Released: February 16, 2021

Expires: February 15, 2022

Activities

ADCs in NSCLC
An Expert Perspective on Antibody–Drug Conjugates in Non-Small-Cell Lung Cancer
Clinical Thought
Conference Coverage
Congratulations: You achieved a completion on 04/09/2022

Released: January 26, 2021

Expires: January 25, 2022

WCLC 2020: Novel ADCs
WCLC 2020: What’s New With Novel Antibody–Drug Conjugates in Non-Small-Cell Lung Cancer
Clinical Thought
Conference Coverage
Congratulations: You achieved a completion on 04/09/2022

Released: March 08, 2021

Expires: March 07, 2022

No activities added yet

Provided by

ProCE Banner

Supporters

Supported by an educational grant from

Daiichi Sankyo, Inc.